INTERNATIONAL PATENT: SEAGEN INC. FILES APPLICATION FOR "ANTI-PD-L1 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER"

GENEVA, Aug. 11 -- SEAGEN INC. (21823 30th Drive SEBothell, Washington 98021) filed a patent application (PCT/IB2025/050885) for "ANTI-PD-L1 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER" on Jan 27, 2025. With publication no. WO/2025/163468, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FORERO-TORRES, Andres (c/o Seagen Inc.21823 30th Drive SEBothell, Washington 98021)

Abstract: Provided are methods and compositions for treating cancer, such as non-small cell lung cancer, head and n...